File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: T-Cell project: An international, longitudinal, observational study of patients with aggressive peripheral T-cell lymphoma | Projeto de célula-T: Estudo internacional, longitudinal de pacientes com linfoma de célula-T periférica agressivo

TitleT-Cell project: An international, longitudinal, observational study of patients with aggressive peripheral T-cell lymphoma | Projeto de célula-T: Estudo internacional, longitudinal de pacientes com linfoma de célula-T periférica agressivo
Authors
KeywordsChemotherapy
Epidemiology
Outcome
T-Cell Lymphoma
Issue Date2009
PublisherSociedade Brasileira de Hematologia e Hemoterapia. The Journal's web site is located at http://www.scielo.br/scielo.php?script=sci_serial&pid=1516-8484&lng=en&nrm=iso
Citation
Revista Brasileira De Hematologia E Hemoterapia, 2009, v. 31 SUPPL. 2, p. 21-25 How to Cite?
AbstractPeripheral T-cell lymphomas (PTCLs) comprise a heterogeneous group of neoplasms that are derived from post-thymic lymphoid cells at different stages of differentiation and with different morphological patterns, phenotypes, and clinical presentations. PTCLs are highly diverse, reflecting the diverse cells from which they can originate and are currently sub-classified using World Health Organization (WHO) 2008 criteria. Peripheral T-Cell Lymphomas account for 5%-10% of all lymphoproliferative disorders in the Western hemisphere, with an overall incidence of 0.5-2 per 100,000 individuals per year, and have a striking epidemiological distribution, with higher incidence in Asia. The clinical features of PTCL are extremely heterogeneous. PTCLs express even more clinical diversity than B-cell non-Hodgkin's lymphomas, and there is a close, though not absolute, relationship between some unusual clinical features and certain histological subtypes.
Persistent Identifierhttp://hdl.handle.net/10722/163277
ISSN
2015 SCImago Journal Rankings: 0.302
References

 

DC FieldValueLanguage
dc.contributor.authorFederico, Men_US
dc.contributor.authorBellei, Men_US
dc.contributor.authorPesce, Een_US
dc.contributor.authorZucca, Een_US
dc.contributor.authorPileri, Sen_US
dc.contributor.authorMontoto, Sen_US
dc.contributor.authorWeisenburger, DDen_US
dc.contributor.authorRuediger, Ten_US
dc.contributor.authorKo, YHen_US
dc.contributor.authorLiang, Ren_US
dc.contributor.authorZinzani, PLen_US
dc.contributor.authorConnors, JMen_US
dc.contributor.authorFoss, FMen_US
dc.contributor.authorHorwitz, SMen_US
dc.contributor.authorPolliack, Aen_US
dc.contributor.authorVose, JMen_US
dc.date.accessioned2012-09-05T05:29:34Z-
dc.date.available2012-09-05T05:29:34Z-
dc.date.issued2009en_US
dc.identifier.citationRevista Brasileira De Hematologia E Hemoterapia, 2009, v. 31 SUPPL. 2, p. 21-25en_US
dc.identifier.issn1516-8484en_US
dc.identifier.urihttp://hdl.handle.net/10722/163277-
dc.description.abstractPeripheral T-cell lymphomas (PTCLs) comprise a heterogeneous group of neoplasms that are derived from post-thymic lymphoid cells at different stages of differentiation and with different morphological patterns, phenotypes, and clinical presentations. PTCLs are highly diverse, reflecting the diverse cells from which they can originate and are currently sub-classified using World Health Organization (WHO) 2008 criteria. Peripheral T-Cell Lymphomas account for 5%-10% of all lymphoproliferative disorders in the Western hemisphere, with an overall incidence of 0.5-2 per 100,000 individuals per year, and have a striking epidemiological distribution, with higher incidence in Asia. The clinical features of PTCL are extremely heterogeneous. PTCLs express even more clinical diversity than B-cell non-Hodgkin's lymphomas, and there is a close, though not absolute, relationship between some unusual clinical features and certain histological subtypes.en_US
dc.languageengen_US
dc.publisherSociedade Brasileira de Hematologia e Hemoterapia. The Journal's web site is located at http://www.scielo.br/scielo.php?script=sci_serial&pid=1516-8484&lng=en&nrm=isoen_US
dc.relation.ispartofRevista Brasileira de Hematologia e Hemoterapiaen_US
dc.subjectChemotherapyen_US
dc.subjectEpidemiologyen_US
dc.subjectOutcomeen_US
dc.subjectT-Cell Lymphomaen_US
dc.titleT-Cell project: An international, longitudinal, observational study of patients with aggressive peripheral T-cell lymphoma | Projeto de célula-T: Estudo internacional, longitudinal de pacientes com linfoma de célula-T periférica agressivoen_US
dc.typeArticleen_US
dc.identifier.emailLiang, R:rliang@hku.hken_US
dc.identifier.authorityLiang, R=rp00345en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.scopuseid_2-s2.0-70350188837en_US
dc.identifier.hkuros180749-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-70350188837&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume31en_US
dc.identifier.issueSUPPL. 2en_US
dc.identifier.spage21en_US
dc.identifier.epage25en_US
dc.publisher.placeBrazilen_US
dc.identifier.scopusauthoridFederico, M=7101629810en_US
dc.identifier.scopusauthoridBellei, M=36949555500en_US
dc.identifier.scopusauthoridPesce, E=35105684800en_US
dc.identifier.scopusauthoridZucca, E=7005642626en_US
dc.identifier.scopusauthoridPileri, S=36041985800en_US
dc.identifier.scopusauthoridMontoto, S=8341482100en_US
dc.identifier.scopusauthoridWeisenburger, DD=7102337715en_US
dc.identifier.scopusauthoridRuediger, T=6507509664en_US
dc.identifier.scopusauthoridKo, YH=16646069600en_US
dc.identifier.scopusauthoridLiang, R=26643224900en_US
dc.identifier.scopusauthoridZinzani, PL=7101791122en_US
dc.identifier.scopusauthoridConnors, JM=7102927698en_US
dc.identifier.scopusauthoridFoss, FM=7005078005en_US
dc.identifier.scopusauthoridHorwitz, SM=7101770477en_US
dc.identifier.scopusauthoridPolliack, A=7101649469en_US
dc.identifier.scopusauthoridVose, JM=35239028600en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats